FDA Commissioner-apparent Jane Henney, MD, has support from H&BA industry.
This article was originally published in The Rose Sheet
Executive Summary
FDA COMMISSIONER-DESIGNATE HENNEY BEGINS CAPITOL HILL ROUNDS, following the White House announcement of its "intent to nominate" University of New Mexico VP-Health Sciences Jane Henney, MD, as FDA commissioner June 23. While the Senate confirmation process cannot begin until a formal nomination is made, Henney will now be able to meet with Labor & Human Resources Committee members in a semi-official capacity to begin to address questions about her qualifications and plans for the agency.